Core A: Biospecimen Repository and Pathology
- Institution
- SLOAN-KETTERING INST CAN RESEARCH, NY
- Principal investigator
- Cristina R Antonescu
- Funding
- $218K
- Duration
- 2018–2029
Moonbase score
Still being scored
Abstract
CF1: Biospecimen Repository and Pathology Core ABSTRACT The Biospecimen Repository and Pathology Core (CF1) is designed to provide support to the basic and translational research efforts of the SPORE. CF1 will play a central role in collecting, annotating, storing, distributing, and tracking of tissue and blood biospecimens from patients enrolled in research protocols. The Core will provide SPORE investigators with expert histopathological evaluation of tumor samples both from patients enrolled on research protocols and from murine and xenograft models. Additionally it will assist in selecting appropriate formalin-fixed, paraffin-embedded (FFPE) tissue and snap-frozen tissue for research and pilot projects, as well as enable the creation of tissue microarrays (TMAs) for SPORE investigator studies. CF1 will assist in performing and interpreting immunohistochemical studies and fluorescence in situ hybridization (FISH) assays. It will provide scanning and digital archiving of TMA images and reliable interpretation, scoring, and archiving of IHC results from FFPE or TMA sections. CF1 will also provide systematic assessment of tumor response to therapy in human tissues and in sarcoma murine models, including interpretation of immunohistochemical markers for drug response, such as changes in kinase phosphorylation, proliferation inhibition, and induction of apoptosis. It will also provide a centralized resource for mutational annotation of sarcoma samples and cell lines using the MSK-IMPACT platform. Finally, CF1 ensures linkage of specimens to the clinical sarcoma database (within CRDB) in collaboration with project leaders, the Biostatistics and Bioinformatics Core (CF2 Qin/Socci) and the Administrative Core (Singer). This establishes a substantial infrastructure and allows us to provide the required services in a cost-effective manner. CF1 is tightly integrated with the MSK institutional Pathology Core (supported by the MSK Cancer Center Core Grant) and the sarcoma clinical database managed by the Administrative Core.
LOADING MOONBASE SCORE
Questions for SLOAN-KETTERING INST CAN RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Sloan-Kettering Inst Can Research60
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · $80K · 2025
- NIH · Sloan-Kettering Inst Can Research51
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ping Chi · $576K · 2022–2026
- NIH · Sloan-Kettering Inst Can Research49
Targeting stem-like cells and their niche in pancreatic cancer
Tuomas Tammela · $491K · 2025–2026